Trials / Completed
CompletedNCT01777438
Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 434 (actual)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- All
- Age
- 19 Years – 59 Years
- Healthy volunteers
- Accepted
Summary
Allergic rhinitis (AR) is defined as inflammation of the nasal mucosa after exposition to an allergen in sensitized patients. AR causes not only nasal symptoms such as sneezing, itchy nose, rhinorrhea and nasal obstruction, but also has a significant impact on quality of life. Symptom control and overall satisfaction in patients undergoing subcutaneous immunotherapy (SCIT) or sublingual immunotherapy (SLIT) on the long term has not yet been investigated so far.
Conditions
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2013-01-28
- Last updated
- 2013-12-17
- Results posted
- 2013-12-17
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01777438. Inclusion in this directory is not an endorsement.